We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




44th IHF World Hospital Congress Presents Over 60 Plenary Sessions and 200 Renowned Speakers Across Four-Day Event

By HospiMedica International staff writers
Posted on 17 Sep 2021
The 44th World Hospital Congress organized by The International Hospital Federation (Geneva, Switzerland) will bring together more than 200 healthcare experts, leading industry thinkers, and best practice presenters at over 60 sessions around nursing leadership, humanizing technology, COVID-19 vaccination, the next global pandemic, etc.

The 2021 World Hospital Congress is set to take place on 8-11 November in Barcelona, Spain and will be one of the first hybrid healthcare management events that will take place in Europe in 2021. More...
Offering a compelling mix of sessions, posters, IHF Awards, hospital visits, networking opportunities, social activities, and an industry exhibition, the event will provide a comprehensive experience. And for those unable to travel, virtual access is available. All sessions will be live-streamed in a dedicated event platform and recordings will be made available to all attendees for on-demand viewing.

With the overarching theme "People on board: Transforming healthcare by blending agility, responsiveness, and resilience", the 44th World Hospital Congress will present over 60 sessions where more than 200 renowned speakers will gather to share their knowledge and good practices on healthcare transformations enacted across the globe. Among several sessions across the four-day event, the more thought-provoking ones include “Getting ready for the next global pandemic: European and North American perspectives” in which public health leaders from Europe and North America will share their views on how the next pandemic might unfold; how they are leading their organizations to address the next pandemic with the lessons learned from COVID-19; and the changes needed in their organizations and local health systems to effectively respond to the next public health crisis.

The speakers at this plenary session will include Dr. Rod Hochman, M.D., president and CEO of Providence; Dr. Natasha Azzopardi-Muscat, Director of the Division of Country Health Policies and Systems at WHO Regional Office for Europe and Associate Professor at the University of Malta; Dr. JM. Campistol, nephrologist and current General Director of the Hospital Clínic de Barcelona; Dr. Bechara Choucair, MD, White House COVID-19 Vaccinations Coordinator; Wright L. Lassiter III, President and CEO of Henry Ford Health System; and Bertrand Levrat, CEO of the University Hospitals of Geneva (HUG), the largest university hospital in Switzerland.

Another thought-provoking plenary session “Accelerating research, development and distribution of the COVID-19 vaccine: Lessons learned from key stakeholders” will focus on ways to accelerate translational research, transform the way vaccines are developed and distributed and utilize new partnerships and collaborations from industry, governments and global public health actors. This session will also explore the drivers and constrains for such an agile and good response to the crisis, as well as the key learnings that can be gleaned from the different stakeholders for the near future. The session will be chaired by Dr. Hans Kluge, Regional Director for Europe, World Health Organization and will also include other participants such as Dr. Carmen Cabezas, Secretary of Public Health at Department of Health of the Generalitat de Catalunya, Spain; Thomas Cueni, Director General at International Federation of Pharmaceutical Manufacturers & Associations; Dr. César Hernández, Head of Department of Medicines for Human Use at Spanish Agency for Medicines and Medical Devices, Spain; and Dr. John Nkengasong, Director at Africa Centers for Disease Control and Prevention, Ethiopia.

Related Links:
The International Hospital Federation


Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Enteral Feeding Pump
Instilar 1420
New
Mobile X-Ray Machine
MARS 15 / 30
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: the deep tissue in vivo sound printing (DISP) platform, which combines ultrasound with low-temperature–sensitive liposomes loaded with crosslinking agents (Photo courtesy of Elham Davoodi and Wei Gao/Caltech)

New Ultrasound-Guided 3D Printing Technique to Help Fabricate Medical Implants

3D bioprinting technologies hold considerable promise for advancing modern medicine by enabling the production of customized implants, intricate medical devices, and engineered tissues designed to meet... Read more

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.